SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-18-065780
Filing Date
2018-12-20
Accepted
2018-12-20 17:28:10
Documents
7
Period of Report
2018-12-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv509657_8k.htm 8-K 31434
2 EXHIBIT 10.1 tv509657_ex10-1.htm EX-10.1 26158
3 EXHIBIT 10.2 tv509657_ex10-2.htm EX-10.2 82722
4 EXHIBIT 99.1 tv509657_ex99-1.htm EX-99.1 10845
5 GRAPHIC tv509657_ex10-1img1.jpg GRAPHIC 12159
6 GRAPHIC tv509657_ex10-1img2.jpg GRAPHIC 9995
7 GRAPHIC tv509657_ex99-1img1.jpg GRAPHIC 5002
  Complete submission text file 0001144204-18-065780.txt   190268
Mailing Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045
Business Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045 847-279-6100
AKORN INC (Filer) CIK: 0000003116 (see all company filings)

IRS No.: 720717400 | State of Incorp.: LA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32360 | Film No.: 181247053
SIC: 2834 Pharmaceutical Preparations